Long QT Syndrome historical perspective

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assistant Editor(s)-In-Chief: William Patrick, B.S.


Long QT Syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Long QT Syndrome from other Diseases

Epidemiology and Demographics

Risk Stratification

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Genetic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Long QT Syndrome historical perspective On the Web

Most recent articles

Most cited articles

Review articles

Programs

slides

[2]

American Roentgen Ray Society Images of Long QT Syndrome historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

on Long QT Syndrome historical perspective

CDC onLong QT Syndrome historical perspective

QT Syndrome historical perspective in the news

on Long QT Syndrome historical perspective

Directions to Hospitals Treating Long QT Syndrome

Risk calculators and risk factors for Long QT Syndrome historical perspective

Overview

Long QT syndrome (LQTS) was first documented in the mid 1800’s. Since then, LQTS has been the focus of further characterization. By the 1990’s the majority of investigative focus on LQTS has been on elucidating its genetic underpinnings. The first complete description of LQTS came in 1957 when Anton Jarvell and Fred Lange-Nielson described a specific form of LQTS that would become known as “Jervell and Lange-Nielsen Syndrome”.

Historical Perspective

  • In 1856, the German physician Friedrich Ludwig Meissner witnessed a deaf girl collapse and die after being sternly admonished at school.[1] This is the earliest record of what is thought to have been a stress-induced, fatal, cardiac arrhythmia. Current understanding of the pathophysiology of long QT syndrome (LQTS) indicates stress as a known trigger for an elongated QT interval and subsequent fatal arrhythmia. Furthermore, mutations in LQT1, an LQTS loci, have been identified as the most common form of LQTS.
  • In the years following, there were several accounts of familial-associated syncope and deafness that occasionally resulted in death. By the 1950’s electrocardiography was a well established and defined method for observation and diagnoses. The advent of a robust electrocardiogram (ECG) allowed for the precise measurement of intervals between different lines on ECG that by then had been been established as reliable markers of cardiac electrical events.
  • In 1953, a physician examining the ECG of a deaf boy suffering from frequent syncopes was the first to document what would become the prominent diagnostic feature and namesake of LQTS - the prolonged QT interval. The first complete description of LQTS came in 1957 when Anton Jarvell and Fred Lange-Nielson described a specific form of LQTS that would become known as “Jervell and Lange-Nielsen Syndrome”.
  • By the early 1990’s, it was becoming clear that LQTS was more than a strict “electrical” disease, but one which also conferred mechanical abnormalities to heart. Furthermore, for the first time, LQTS was discovered to be linked to a particular locus on chromosome 11 called the Harvey ras-1 gene locus. This sparked a rapid and significant endeavor to elucidate the genetic underpinnings of LQTS. By the mid 1990’s three genes had been discovered as LQTS loci.
  • To date, many more LQTS loci have been discovered. These loci affect a diverse group of cardiac ion channels and the supporting cast of proteins which orchestrate the cardiac action potential. Most of these mutations are implicit in the three most prominent types of LQTS including LQT1, LQT2, and LQT3. Sudden cardiac death is responsible for the greatest number of deaths in the U.S. every year compared to other major disease processes.[2] In fact, it is the cause of more deaths than stroke, lung cancer, breast cancer, and aids combined. Thus, a long term goal of these efforts continues to be the development of insightful and clinically-relevant risk stratification algorithms to better predict and treat LQTS in at-risk patients.

References

  1. "QTsyndrome.ch - History Of a Heart Disease".
  2. Zheng ZJ, Croft JB, Giles WH, Mensah GA (2001). "Sudden cardiac death in the United States, 1989 to 1998". Circulation. 104 (18): 2158–63. PMID 11684624. Unknown parameter |month= ignored (help)